Huberman takes a daily longevity supplement he says won't extend his life
In a recent appearance reported September 26, 2026, Andrew Huberman — one of the most influential health voices in the world — said he takes a longevity supplement daily “for the effect it appears to give me” while explicitly stating it won't help him live longer. It is a remarkable admission: personal use decoupled from the longevity claim that sells the product.
What evidence did he cite?
Huberman pointed to a 2026 systematic review finding that NAD-boosting interventions show biomarker changes but inconclusive anti-aging and wellness benefits in humans. That matches this site's own coverage: blood-NAD+ numbers move; human outcomes don't — at least not in the published record.
Why does this matter for the watchdog desk?
Expert voices shape consumer behavior. When a leading voice separates how a supplement feels from what it can prove, it models the evidence-first stance this site takes: effects you feel are real to you, but they are not longevity data.
How does this connect to mitochondrial health?
NAD-boosting supplements are marketed on mitochondrial promises — NAD+ fuels mitochondrial enzymes. The honest framing is that mitochondrial plausibility plus inconclusive human data equals a personal experiment, not a longevity strategy.
Where the evidence stands
- Established: NAD-boosting interventions change biomarkers, including blood NAD+ levels.
- Contested: Whether those changes translate into wellness or anti-aging benefits in humans is inconclusive — per the 2026 systematic review Huberman cited.
- Absent: No human trial shows a daily longevity supplement extends lifespan.